Literature DB >> 12440940

The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration.

J F Huggett1, A Mustafa, L O'neal, D J Mason.   

Abstract

The glutamate/aspartate transporter GLAST-1 is expressed in bone in vivo and also exists as a splice variant (GLAST-1a) in which exon 3 is excluded. Since GLAST-1 expression is regulated in bone in response to osteogenic mechanical stimuli in vivo and binding of glutamate to receptors on osteoblasts increases osteoblast number and activity in vitro, control of extracellular glutamate concentrations may be critical for balanced bone remodelling. To determine whether GLAST isoforms may act to regulate extracellular glutamate concentration in bone we investigated whether their pattern or level of expression is responsive to glutamate concentration in bone cells. GLAST-1a mRNA is expressed at lower levels than GLAST-1 mRNA in all cells examined. The GLAST-1a/GLAST-1 mRNA ratio is greater in MLO-Y4 osteocytes than in SaOS-2 osteoblast-like cells, although this does vary in SaOS-2 cells in response to extracellular glutamate concentration. Transfection of MLO-Y4 cells with green fluorescent protein (GFP)-tagged GLAST isoforms revealed a plasma membrane localization of GLAST-1, consistent with its transporter function, whereas GLAST-1a appeared to be expressed within internal vesicles. Interestingly, low extracellular glutamate concentrations redistributed GLAST-1-GFP into a similar internal expression pattern. Regulation of the expression and distribution of GLAST-1 by extracellular glutamate in bone cells indicates that it may regulate glutamate signalling in bone, consistent with its operation in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12440940     DOI: 10.1042/bst0300890

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  6 in total

1.  Excitatory amino acids display compartmental disparity between plasma and synovial fluid in clinical arthropathies.

Authors:  Terry A McNearney; Karin N Westlund
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

2.  A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes.

Authors:  Terry A McNearney; Yinghong Ma; Yueping Chen; Giulio Taglialatela; Huaizhi Yin; Wen-Ru Zhang; Karin N Westlund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

Review 3.  Amino acid metabolism and autophagy in skeletal development and homeostasis.

Authors:  Akiko Suzuki; Junichi Iwata
Journal:  Bone       Date:  2021-02-10       Impact factor: 4.398

Review 4.  Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders.

Authors:  Georgia M Parkin; Madhara Udawela; Andrew Gibbons; Brian Dean
Journal:  World J Psychiatry       Date:  2018-06-28

5.  Glutamate signaling in healthy and diseased bone.

Authors:  Robert W Cowan; Eric P Seidlitz; Gurmit Singh
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-19       Impact factor: 5.555

6.  Glutamate signaling in bone.

Authors:  Karen S Brakspear; Deborah J Mason
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-06       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.